Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Faron Pharmaceuticals Oy ( (GB:FARN) ) just unveiled an announcement.
Faron Pharmaceuticals Ltd announced the grant of 180,000 options over ordinary shares under its Share Option Plan 2019. These options, exercisable between December 2026 and December 2031, represent 0.16% of the company’s fully diluted share capital and are aimed at incentivizing directors and other personnel, potentially impacting the company’s operational dynamics and stakeholder interests.
More about Faron Pharmaceuticals Oy
Faron Pharmaceuticals Ltd is a global, clinical-stage biopharmaceutical company focused on developing novel immunotherapies to tackle cancers. The company’s mission is to expand the reach of immunotherapy by discovering new methods to control and harness the immune system’s power.
For an in-depth examination of FARN stock, go to TipRanks’ Overview page.